Veytics Intelligence
2026-09-12 · NASDAQ

How Concerned Should Income Investors Be About Pfizer's Dividend?

Key Points Pfizer is one of the world's best-known drug companies, offering a well-above-market dividend yield. The company is facing typical industry headwinds, which make the dividend look risky. 10 stocks we like better than Pfizer › Pfizer (NYSE: PFE) is not hitting on all cylinders today. That's why the stock is down more than 50% from its 2021 high, as of this writing, and its payout ratio is well north of 100%. Dividend investors may find the huge 6% yield attractive, but before buying, you have to ask if that dividend is actually sustainable. The answer is likely yes, here's why. Dividends don't come out of earnings The financial impact of dividends shows up on the cash flow statement, not the earnings statement.

Przeczytaj pelny brief Veytics

Publicznie pokazujemy glowna mysl. Utworz darmowe konto, aby czytac caly artykul, zapisac go, omowic i polaczyc z kontekstem rynkowym oraz OSINT.